German Adrenocortical Carcinoma Registry

Rekrutierend

NCT-Nummer:
NCT00453674

Studienbeginn:
Januar 2003

Letztes Update:
24.04.2024

Wirkstoff:
-

Indikation (Clinical Trials):
Carcinoma, Adrenocortical Carcinoma

Geschlecht:
Alle

Altersgruppe:
Alle

Phase:
-

Sponsor:
University of Wuerzburg

Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany)

Studienleiter

Martin Fassnacht, MD
Principal Investigator
University of Wuerzburg

Kontakt

Martin Fassnacht, MD
Kontakt:
Phone: 49-931-201-36507
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de» Kontaktdaten anzeigen

Michaela Haaf
Kontakt:
E-Mail: haaf_m@ukw.de» Kontaktdaten anzeigen

Studienlocations
(1 von 1)

University of Wuerzburg
97080 Wuerzburg
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Martin Fassnacht, MD
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de» Ansprechpartner anzeigen

Studien-Informationen

Brief Summary:

Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of

patients with adrenocortical cancer. The registration of as many patients as possible helps

to collect data for the prognosis and prospects of success regarding different treatment

plans. This data will be taken into consideration for planning prospective studies. With this

registry, the recruitment of patients for prospective studies will be significantly

facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy

and France) - a structure allowing systematic improvement of therapy will be developed.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Histologically confirmed diagnosis of adrenocortical carcinoma

Quelle: ClinicalTrials.gov